Managing Complex Clinical Supply Chain in Unpredictable EAP Scenarios
- Case study: Maintaining patient treatment in Israel during conflict
- Highlighting issues/regions without a defined EAP framework
- Coordinating supply with EAP vendors. Navigating label regulatory ambiguity when clinical trial programs wind down, assets transfer, or treatment continues beyond planned timelines to maintain patient access
- Discussing practical lessons from a pharmacist’s end-user perspective to streamline investigations drug service operations and patient delivery